The type III TGF-β receptor suppresses breast cancer progressionMei Dong, Gerard C. Blobe|Journal of Clinical Investigation|2006Cited by 255
XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cellsTeng Xue, Mei Dong|Oncology Reports|2019Cited by 33